110 related articles for article (PubMed ID: 29502025)
21. High-throughput screen identifies novel inhibitors of cancer biomarker α-methylacyl coenzyme A racemase (AMACR/P504S).
Wilson BA; Wang H; Nacev BA; Mease RC; Liu JO; Pomper MG; Isaacs WB
Mol Cancer Ther; 2011 May; 10(5):825-38. PubMed ID: 21441411
[TBL] [Abstract][Full Text] [Related]
22. Unexpected stereoselective exchange of straight-chain fatty acyl-CoA alpha-protons by human alpha-methylacyl-CoA racemase 1A (P504S).
Sattar FA; Darley DJ; Politano F; Woodman TJ; Threadgill MD; Lloyd MD
Chem Commun (Camb); 2010 May; 46(19):3348-50. PubMed ID: 20442897
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and use of isotope-labelled substrates for a mechanistic study on human alpha-methylacyl-CoA racemase 1A (AMACR; P504S).
Darley DJ; Butler DS; Prideaux SJ; Thornton TW; Wilson AD; Woodman TJ; Threadgill MD; Lloyd MD
Org Biomol Chem; 2009 Feb; 7(3):543-52. PubMed ID: 19156321
[TBL] [Abstract][Full Text] [Related]
24. Malonate-based inhibitors of mammalian serine racemase: kinetic characterization and structure-based computational study.
Vorlová B; Nachtigallová D; Jirásková-Vaníčková J; Ajani H; Jansa P; Rezáč J; Fanfrlík J; Otyepka M; Hobza P; Konvalinka J; Lepšík M
Eur J Med Chem; 2015 Jan; 89():189-97. PubMed ID: 25462239
[TBL] [Abstract][Full Text] [Related]
25. Expanding the chemical space of human serine racemase inhibitors.
Dellafiora L; Marchetti M; Spyrakis F; Orlandi V; Campanini B; Cruciani G; Cozzini P; Mozzarelli A
Bioorg Med Chem Lett; 2015 Oct; 25(19):4297-303. PubMed ID: 26283510
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of mandelate racemase by alpha-fluorobenzylphosphonates.
St Maurice M; Bearne SL; Lu W; Taylor SD
Bioorg Med Chem Lett; 2003 Jun; 13(12):2041-4. PubMed ID: 12781191
[TBL] [Abstract][Full Text] [Related]
27. Structural Characterization of Alpha-methylacyl-CoA Racemase: Comparative Structural Modeling, Molecular Docking and Dynamic Simulations Studies.
Abbasi SW; Azam SS
Curr Cancer Drug Targets; 2015; 15(9):822-35. PubMed ID: 26567883
[TBL] [Abstract][Full Text] [Related]
28. The perils of rational design--unexpected irreversible elimination of fluoride from 3-fluoro-2-methylacyl-CoA esters catalysed by α-methylacyl-CoA racemase (AMACR; P504S).
Yevglevskis M; Lee GL; Threadgill MD; Woodman TJ; Lloyd MD
Chem Commun (Camb); 2014 Nov; 50(91):14164-6. PubMed ID: 25277991
[TBL] [Abstract][Full Text] [Related]
29. Chiral inversion of 2-arylpropionyl-CoA esters by human α-methylacyl-CoA racemase 1A (P504S)--a potential mechanism for the anti-cancer effects of ibuprofen.
Woodman TJ; Wood PJ; Thompson AS; Hutchings TJ; Steel GR; Jiao P; Threadgill MD; Lloyd MD
Chem Commun (Camb); 2011 Jul; 47(26):7332-4. PubMed ID: 21614403
[TBL] [Abstract][Full Text] [Related]
30. Purification and properties of an alpha-methylacyl-CoA racemase from rat liver.
Schmitz W; Fingerhut R; Conzelmann E
Eur J Biochem; 1994 Jun; 222(2):313-23. PubMed ID: 8020470
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and evaluation of novel inhibitors for wild-type human serine racemase.
Takahara S; Nakagawa K; Uchiyama T; Yoshida T; Matsumoto K; Kawasumi Y; Mizuguchi M; Obita T; Watanabe Y; Hayakawa D; Gouda H; Mori H; Toyooka N
Bioorg Med Chem Lett; 2018 Feb; 28(3):441-445. PubMed ID: 29277459
[TBL] [Abstract][Full Text] [Related]
32. In silico and pharmacological screenings identify novel serine racemase inhibitors.
Mori H; Wada R; Li J; Ishimoto T; Mizuguchi M; Obita T; Gouda H; Hirono S; Toyooka N
Bioorg Med Chem Lett; 2014 Aug; 24(16):3732-5. PubMed ID: 25066953
[TBL] [Abstract][Full Text] [Related]
33. α-Methylacyl-CoA Racemase from
Mojanaga OO; Woodman TJ; Lloyd MD; Acharya KR
Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540719
[TBL] [Abstract][Full Text] [Related]
34. Structure-based inhibitor design of AccD5, an essential acyl-CoA carboxylase carboxyltransferase domain of Mycobacterium tuberculosis.
Lin TW; Melgar MM; Kurth D; Swamidass SJ; Purdon J; Tseng T; Gago G; Baldi P; Gramajo H; Tsai SC
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3072-7. PubMed ID: 16492739
[TBL] [Abstract][Full Text] [Related]
35. Cyclopropane derivatives as potential human serine racemase inhibitors: unveiling novel insights into a difficult target.
Beato C; Pecchini C; Cocconcelli C; Campanini B; Marchetti M; Pieroni M; Mozzarelli A; Costantino G
J Enzyme Inhib Med Chem; 2016 Aug; 31(4):645-52. PubMed ID: 26133542
[TBL] [Abstract][Full Text] [Related]
36. Intermediate analogue inhibitors of mandelate racemase: N-Hydroxyformanilide and cupferron.
Bourque JR; Burley RK; Bearne SL
Bioorg Med Chem Lett; 2007 Jan; 17(1):105-8. PubMed ID: 17055725
[TBL] [Abstract][Full Text] [Related]
37. Purification and characterization of an alpha-methylacyl-CoA racemase from human liver.
Schmitz W; Albers C; Fingerhut R; Conzelmann E
Eur J Biochem; 1995 Aug; 231(3):815-22. PubMed ID: 7649182
[TBL] [Abstract][Full Text] [Related]
38. Nanomolar competitive inhibitors of Mycobacterium tuberculosis and Streptomyces coelicolor type II dehydroquinase.
Prazeres VF; Sánchez-Sixto C; Castedo L; Lamb H; Hawkins AR; Riboldi-Tunnicliffe A; Coggins JR; Lapthorn AJ; González-Bello C
ChemMedChem; 2007 Feb; 2(2):194-207. PubMed ID: 17245805
[TBL] [Abstract][Full Text] [Related]
39. Structure of mycobacterial β-oxidation trifunctional enzyme reveals its altered assembly and putative substrate channeling pathway.
Venkatesan R; Wierenga RK
ACS Chem Biol; 2013 May; 8(5):1063-73. PubMed ID: 23496842
[TBL] [Abstract][Full Text] [Related]
40. Slow-binding human serine racemase inhibitors from high-throughput screening of combinatorial libraries.
Dixon SM; Li P; Liu R; Wolosker H; Lam KS; Kurth MJ; Toney MD
J Med Chem; 2006 Apr; 49(8):2388-97. PubMed ID: 16610782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
